Technology Transfer

NIDCR的技术转让办公室在2012财年处理了300份材料转让、保密和合作协议。NIDCR保持大约5：1的出料与进料比例。截至8月中旬，2012财年有4个新的许可证，涉及疫苗和基因治疗相关的治疗产品，以及诊断和基础研究产品。预计2012财年的特许权使用费总额将超过NIDCR技术转让办公室的分配预算。四个员工发明报告被提交。 贸发局办事处被要求帮助处理动物转移协议，作为回应，该办事处与VRC和高容量用户密切合作，制定程序，以满足这一要求。 新的程序和协议表格（根据NIDCR政策批准的508K）预计将改善对内部和外部客户的服务。 以贸易发展局为例，该局回应了约5，000封电子邮件及查询，反映出该局处理的工作量庞大。 NIDCR的第一个临床CRADA的资金足以支持一个全职的研究职位和一个分析咀嚼口香糖对唾液流动影响的项目。 布拉德利博士在大学技术管理人员协会（AUTM）东部区域会议上发言并参加了关于道德和技术转让的小组讨论。 为了提高效率并为NIDCR研究人员提供更好的服务，TDC办公室达成共识，采用电子接受协议，使质粒通过Addgene分配。 该办公室通过制定终止遗留协议的程序，改善了对记录保留规则的遵守情况。

NIDCR's technology transfer office processed 300 material transfer, confidentiality, and collaborative agreements in FY 2012. NIDCR maintains an approximate 5:1 ratio of outgoing materials as compared to incoming materials. As of mid-August, there were 4 new licenses executed in FY2012 for therapeutic products related to vaccines and gene therapy, as well as diagnostic and basic research products. Total royalties for FY2012 are expected to exceed the allocated budget for the NIDCR technology transfer office. Four Employee Invention Reports were filed. The TDC Office was asked to help process Animal Transfer Agreements, and in response, the office worked closely with the VRC and high-volume users to establish procedures to accommodate this request. The new procedures and agreement form (508K approved in accordance with NIDCR policy) is expected to improve service for internal and external customers. The volume of communicationsfor example, the TDC responded to approximately 5,000 emails and inquiresreflects the large workload processed by this office. Funds from NIDCRs first clinical CRADA were sufficient to support a full-time research position and a project analyzing the effect of gum chewing on salivary flow. Dr. Bradley spoke and participated in a panel discussion on ethics and technology transfer at the Association of University Technology Managers (AUTM) eastern regional meeting. To improve efficiency and provide better service to NIDCR investigators, the TDC Office built consensus to adopt electronic acceptance of agreements that enable plasmid distribution through Addgene. The office improved compliance with record retention rules by developing a procedure to terminate legacy agreements.